Stay updated on Selinexor Plus DRd in New Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Selinexor Plus DRd in New Multiple Myeloma Clinical Trial page.

Latest updates to the Selinexor Plus DRd in New Multiple Myeloma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check32 days agoNo Change Detected
- Check39 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check47 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check61 days agoChange DetectedThe website has updated its status from 'Recruiting' to 'Active, not recruiting' as of January 16, 2025, reflecting a significant change in its operational status.SummaryDifference2%
- Check68 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
- Check97 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
Stay in the know with updates to Selinexor Plus DRd in New Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor Plus DRd in New Multiple Myeloma Clinical Trial page.